2018

Apr 26

Dr. Kosciessa Assumes COO of SBI ALApharma

(113.2 KB)

Apr 26

Notice Regarding Dividend of Surplus

(88.8 KB)

Apr 26

Notice regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2020 and 2022

(24.1 KB)

Apr 18

Annual Results Announcement for the Fiscal Year Ended March 31, 2018 of SBI SECURITIES

(27.9 KB)

Mar 30

Comprehensive Commercialization Rights Granted to Neopharma on the Pharmaceuticals Containing 5-ALA

(106.1 KB)

Feb 13

Notice Regarding an Investment into T1R, which engages ICO Consultation Business in the U.S.

(74.4 KB)

Feb 5

Notice Regarding Investment into FinTech Venture Companies, which are Affiliated to the Ping An Insurance Group in China

(89.78 KB)

Feb 1

Notice Regarding an Investment into FinanceApp AG

(115.9 KB)

Jan 30

Notice of Memorandum of Understanding on Investing in and Establishing Joint Venture with Movencorp Inc. in the U.S.

(81.6 KB)

Jan 30

Revision of Dividend Forecast for the Fiscal Year Ending March 31, 2018

(83.1 KB)

Jan 25

Presentation of Research Paper on 5-ALA by Yamagata University, Faculty of Medicine to PLOS ONE, a U.S. Scientific Journal ～ 5-ALA Deficiency Attenuates Mitochondrial Function and Impairs Glucose Tolerance ～

(100.2 KB)

Jan 19

Third Quarterly Results Announcement for the Nine Months Ended December 31, 2017 of SBI SECURITIES

(28.5 KB)

Jan 17

Establishment of SBI AI & Blockchain Fund, a Venture Capital Fund Endeavoring to Invest Mainly in AI and Blockchain Fields

(83.4 KB)

• 2017

Adobe Reader
You need to download Adobe Reader to view these PDF files.

• There is no charge for downloading Adobe Reader.
• The logos of Adobe Reader and Adobe Reader are the registered trademarks of Adobe Systems.